To further study resistance mechanisms to JAK inhibitors in CBFA2T3::GLIS2 AML, we developed CBFA2T3::GLIS2 AML cell lines with acquired resistance to JAK inhibitors. This evidence concerns the gene GLIS2 and acute myeloid leukemia.